Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immune Therapeutics Inc (OTCQB:IMUN)

0.024
Delayed Data
As of 3:56pm ET
 +0.001 / +4.35%
Today’s Change
0.02
Today|||52-Week Range
0.09
-52.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$7.7M

Company Description

Immune Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat cancer, HIV or AIDS, autoimmune diseases and immune disorders by combating these chronic and often life-threatening diseases through the stimulation and regulation of the body's immune system. The company was founded by Noreen Griffin on December 2, 1993 and is headquartered in Orlando, FL.

Contact Information

Immune Therapeutics, Inc.
37 North Orange Avenue
Orlando Florida 32801
P:(888) 613-8802
Investor Relations:

Employees

Shareholders

Individual stakeholders6.28%
Mutual fund holders--
Other institutional--

Top Executives

Noreen GriffinChairman & Chief Executive Officer
Rudy J. WilliamsChief Operating Officer
Peter J. AronstamChief Financial Officer
Fengping ShanChief Science Officer
Joseph M. FortunakVice President-Global Research & Development